Dr. Lisa N. Abaid, MD, MPH

Dr. Abaid practices at Hoag Clinic - Newport Beach in Newport Beach, California.

Dr. Abaid's NPI, 1295943132, was assigned on May 21, 2007. Dr. Abaid graduated from University of Miami, Miller School of Medicine in 2000. Dr. Abaid holds California license A104885.

Dr. Abaid's primary practice is Hoag Clinic - Newport Beach, at 510 Superior Ave, Newport Beach, CA 92663. The practice phone is (949) 764-5700.

Dr. Abaid's primary practice is Hoag Clinic - Newport Beach in Newport Beach, California. Dr. Abaid is also affiliated with Hoag Hospital Newport Beach. The medical group on file is Hoag Clinic. Dmand AI also links Dr. Abaid to 2 more hospitals and 1 group practice or clinic, each named with a free account. Dr. Abaid's employer is on file too: an urgent care center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abaid practices, 5 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Abaid's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Abaid is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Abaid's licenses on file in 2 states: California and North Carolina.

Dmand AI lists hysterectomy and ovarian cyst among the conditions Dr. Abaid treats.

CMS data shows 456 Medicare services from Dr. Abaid across 8 procedure codes in 2024, for 221 Medicare patients. Medicare paid $51,452 for them.

CMS counts 221 Medicare patients who saw Dr. Abaid in 2024. The largest group is 65 to 74, with 108 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Abaid's median patient age at 64, with 97% women.

In 2024, Dr. Abaid wrote 145 Medicare Part D claims for 65 patients. 83% of them were for generic drugs. CMS names the drug for 54 of them, across 3 drugs with 11 or more claims each, at $205,110 in total drug cost. In 2023, CMS named 33 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Abaid for performance year 2024, reported as part of a group. Dr. Abaid accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 25 procedures of removal of the uterus by Dr. Abaid, more than 95% of the clinicians it reports for that procedure.

Dmand AI links 49 papers to Dr. Abaid, published from 2007 to 2018. 2009 was the busiest year, with 4. The most frequent topics are Ovarian Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Carboplatin. Dr. Abaid has published most often in J Minim Invasive Gynecol. Dr. Abaid's most frequent co-authors are Alberto Mendivil, MD, Mark A. Rettenmaier, MD and John V. Brown, MD.

CMS Open Payments shows 43 general payments to Dr. Abaid from 12 drug and device companies from 2016 to 2025. Education make up the largest share, 54% of the total. Intuitive Surgical, Inc. paid the most, $10,261.

Dmand AI lists 3 awards for Dr. Abaid, most recently CMS Stage 1 EHR in 2012.

Dr. Abaid graduated from University of Miami, Miller School of Medicine in 2000. Dr. Abaid is a member of American College of Obstetricians and Gynecologists and ACS.

Dr. Abaid is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.